research SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation 2 citations , July 2023 in “Life” COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.
research Online Survey on Perceptions and Practices of Hair Oiling Among Diverse Demographics in the Southern States of India February 2026 in “Indian Dermatology Online Journal” Hair oiling is popular in southern India, but some people experience scalp issues, indicating a need for better guidance.
research Clinical Applications of Essential Oils 1 citations , June 2023 Essential oils can improve health but must be used safely under professional guidance.
research Safety of dermatologic medications in pregnancy and lactation 73 citations , March 2014 in “Journal of The American Academy of Dermatology” Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.
research DERMATOLOGICAL COMPOSITION OF DEODORANTS AND POTENTIAL CUTANEOUS RISKS: A NARRATIVE REVIEW AND CLINICAL IMPLICATIONS January 2026 in “Derecho y cambio social.” Choose deodorants with low allergenic ingredients and follow usage instructions to avoid skin issues.
community Breezula Phase III 12-Month Data Released by Cosmo Pharma in Research/Science 42 upvotes 4 months ago Clascoterone 5% topical solution is effective and safe for long-term use in treating male pattern hair loss. Cosmo Pharma aims for EU and US approval, with a potential US release in late 2027 or early 2028.